HLVX

HilleVax, Inc. - Common Stock (HLVX)

About HilleVax, Inc. - Common Stock (HLVX)

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.

Details

Daily high

$1.73

Daily low

$1.65

Price at open

$1.69

52 Week High

$16.30

52 Week Low

$1.34

Market cap

84.7M

Dividend yield

0.00%

Volume

189,231

Avg. volume

273,401

P/E ratio

-.56

HilleVax, Inc. - Common Stock News